Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2025 Filed Jan 6, 2025 23:22 UTC |
RIKER LAURENSenior Vice President, Finance
|
Tax withholdingCommon Stock | 159 | $18.33 | $2,914.47 |
DisclosureSEC source: 0001396814-25-000005 · wk-form4_1736205763.xml · nonDerivative · entry 1 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,916.335 F1 · kind: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| December 31, 2024 Filed Jan 6, 2025 23:22 UTC |
GAUGLER DARYLChief Operating Officer
|
GrantCommon Stock | 243.537 | $16.01 | $3,900.00 |
DisclosureSEC source: 0001396814-25-000006 · wk-form4_1736205773.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,443.489 F1 · kind: Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2024. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 21:13 UTC |
GAUGLER DARYLChief Operating Officer
|
SaleCommon Stock | 500 | $19.76 | $9,880.00 |
DisclosureSEC source: 0001396814-24-000143 · wk-form4_1734383614.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,199.952 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:42 UTC |
Cross ShawnChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $16.45 | $0.00 |
DisclosureSEC source: 0001396814-24-000135 · wk-form4_1730842931.xml · derivative · entry 2 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-11-04 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:42 UTC |
Cross ShawnChief Financial Officer
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000135 · wk-form4_1730842931.xml · nonDerivative · entry 1 Cross Shawn · CIK 0001734779 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on November 1, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| September 13, 2024 Filed Sep 14, 2024 00:29 UTC |
GAUGLER DARYLChief Operating Officer
|
SaleCommon Stock | 500 | $12.86 | $6,430.00 |
DisclosureSEC source: 0001396814-24-000122 · wk-form4_1726273754.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,699.952 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| August 16, 2024 Filed Aug 19, 2024 12:25 UTC |
Brege LauraDirector
|
PurchaseCommon Stock | 1,000 | $12.81 | $12,810.00 |
DisclosureSEC source: 0001396814-24-000117 · wk-form4_1724070340.xml · nonDerivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,552 Read SEC document |
| August 16, 2024 Filed Aug 19, 2024 12:25 UTC |
BIGAL MARCELODirector
|
PurchaseCommon Stock | 1,512 | $13.25 | $20,034.00 |
DisclosureSEC source: 0001396814-24-000118 · wk-form4_1724070350.xml · nonDerivative · entry 1 BIGAL MARCELO · CIK 0001996637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,142 Read SEC document |
| August 14, 2024 Filed Aug 14, 2024 20:35 UTC |
YANG MICHAEL J.Director
|
PurchaseCommon Stock | 2,000 | $12.90 | $25,800.00 |
DisclosureSEC source: 0001396814-24-000114 · wk-form4_1723667702.xml · nonDerivative · entry 1 YANG MICHAEL J. · CIK 0001702283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,230 Read SEC document |
| August 12, 2024 Filed Aug 12, 2024 20:33 UTC |
Froimson MarkDirector
|
PurchaseCommon Stock | 1,400 | $11.58 | $16,212.00 |
DisclosureSEC source: 0001396814-24-000107 · wk-form4_1723509201.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,473 Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 00:33 UTC |
BIGAL MARCELODirector
|
PurchaseCommon Stock | 3,400 | $12.01 | $40,834.00 |
DisclosureSEC source: 0001396814-24-000106 · wk-form4_1723509190.xml · nonDerivative · entry 1 BIGAL MARCELO · CIK 0001996637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,630 F1 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $12.35, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 20:55 UTC |
Lee Frank D.Director · Chief Executive Officer
|
PurchaseCommon Stock | 8,264 | $12.10 | $99,994.40 |
DisclosureSEC source: 0001396814-24-000112 · wk-form4_1723582498.xml · nonDerivative · entry 1 Lee Frank D. · CIK 0001814686 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,784 Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 12:43 UTC Amendment |
BIGAL MARCELODirector
|
PurchaseCommon Stock | 3,400 | $12.01 | $40,834.00 |
DisclosureSEC source: 0001396814-24-000110 · wk-form4a_1723553015.xml · nonDerivative · entry 1 BIGAL MARCELO · CIK 0001996637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,630 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.75 to $12.35, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote 1. Read SEC document |
| August 02, 2024 Filed Aug 2, 2024 22:00 UTC |
SLONIN JONATHANChief Medical Officer
|
SaleCommon Stock | 945 | $20.05 | $18,947.25 |
DisclosureSEC source: 0001396814-24-000100 · wk-form4_1722636050.xml · nonDerivative · entry 2 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,306.746 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| August 01, 2024 Filed Aug 2, 2024 22:00 UTC |
SLONIN JONATHANChief Medical Officer
|
Tax withholdingCommon Stock | 305 | $20.75 | $6,328.75 |
DisclosureSEC source: 0001396814-24-000100 · wk-form4_1722636050.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,251.746 F1 · kind: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 22:52 UTC |
SLONIN JONATHANChief Medical Officer
|
SaleCommon Stock | 2,836 | $28.25 | $80,117.00 |
DisclosureSEC source: 0001396814-24-000088 · wk-form4_1720047136.xml · nonDerivative · entry 3 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,556.746 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 22:52 UTC |
SLONIN JONATHANChief Medical Officer
|
Tax withholdingCommon Stock | 914 | $28.46 | $26,012.44 |
DisclosureSEC source: 0001396814-24-000088 · wk-form4_1720047136.xml · nonDerivative · entry 2 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,392.746 F2 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 22:52 UTC |
SLONIN JONATHANChief Medical Officer
|
GrantCommon Stock | 437.271 | $24.32 | $10,633.99 |
DisclosureSEC source: 0001396814-24-000088 · wk-form4_1720047136.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,306.746 F1 · kind: Represents shares of common stock acquired under the issuer's employee stock purchase plan in June 2024. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 22:52 UTC |
GAUGLER DARYLChief Operating Officer
|
GrantCommon Stock | 160.368 | $24.32 | $3,899.99 |
DisclosureSEC source: 0001396814-24-000089 · wk-form4_1720047161.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,199.952 F1 · kind: Represents shares of common stock acquired under the issuer's employee stock purchase plan in June 2024. Read SEC document |
| June 13, 2024 Filed Jun 13, 2024 22:12 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 7,452 | $28.38 | $211,487.76 |
DisclosureSEC source: 0001396814-24-000074 · wk-form4_1718316760.xml · nonDerivative · entry 2 WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,912 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 13, 2024 Filed Jun 13, 2024 22:13 UTC |
HASTINGS PAUL JDirector
|
SaleCommon Stock | 880 | $28.38 | $24,974.40 |
DisclosureSEC source: 0001396814-24-000075 · wk-form4_1718316771.xml · nonDerivative · entry 2 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,724 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 13, 2024 Filed Jun 13, 2024 22:13 UTC |
GAUGLER DARYLChief Operating Officer
|
SaleCommon Stock | 1,000 | $28.38 | $28,380.00 |
DisclosureSEC source: 0001396814-24-000078 · wk-form4_1718316809.xml · nonDerivative · entry 2 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,039.584 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:15 UTC |
SLONIN JONATHANChief Medical Officer
|
GrantCommon Stock | 54,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000084 · wk-form4_1718316890.xml · nonDerivative · entry 2 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,869.475 F2 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 18:13 UTC |
Froimson MarkDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,179 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001396814-24-000077 · wk-form4_1718316798.xml · derivative · entry 2 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,179 Underlying: Common Stock · 12,179 shares Expires 2034-06-12 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 18:13 UTC |
Froimson MarkDirector
|
GrantCommon Stock | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000077 · wk-form4_1718316798.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,073 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 18:14 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
GrantCommon Stock | 12,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000081 · wk-form4_1718316843.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,867 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:12 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
GrantCommon Stock | 54,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000074 · wk-form4_1718316760.xml · nonDerivative · entry 1 WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,364 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:13 UTC |
HASTINGS PAUL JDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,179 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001396814-24-000075 · wk-form4_1718316771.xml · derivative · entry 3 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,179 Underlying: Common Stock · 12,179 shares Expires 2034-06-12 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:13 UTC |
HASTINGS PAUL JDirector
|
GrantCommon Stock | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000075 · wk-form4_1718316771.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,604 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:12 UTC |
Brege LauraDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,179 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001396814-24-000073 · wk-form4_1718316748.xml · derivative · entry 2 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,179 Underlying: Common Stock · 12,179 shares Expires 2034-06-12 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:12 UTC |
Brege LauraDirector
|
GrantCommon Stock | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000073 · wk-form4_1718316748.xml · nonDerivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,552 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:15 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 3,970 | $28.72 | $114,018.40 |
DisclosureSEC source: 0001396814-24-000085 · wk-form4_1718316907.xml · nonDerivative · entry 2 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,075.335 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.33 to $29.32, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:15 UTC |
RIKER LAURENSenior Vice President, Finance
|
GrantCommon Stock | 21,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000085 · wk-form4_1718316907.xml · nonDerivative · entry 1 RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,045.335 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:14 UTC |
CHRISTIE CHRISTOPHERDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,179 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001396814-24-000083 · wk-form4_1718316879.xml · derivative · entry 2 CHRISTIE CHRISTOPHER · CIK 0001787688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,179 Underlying: Common Stock · 12,179 shares Expires 2034-06-12 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:14 UTC |
CHRISTIE CHRISTOPHERDirector
|
GrantCommon Stock | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000083 · wk-form4_1718316879.xml · nonDerivative · entry 1 CHRISTIE CHRISTOPHER · CIK 0001787688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,491 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:14 UTC |
BIGAL MARCELODirector
|
GrantStock Option (Right to Buy) · Derivative | 12,179 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001396814-24-000082 · wk-form4_1718316863.xml · derivative · entry 2 BIGAL MARCELO · CIK 0001996637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,179 Underlying: Common Stock · 12,179 shares Expires 2034-06-12 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:14 UTC |
BIGAL MARCELODirector
|
GrantCommon Stock | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000082 · wk-form4_1718316863.xml · nonDerivative · entry 1 BIGAL MARCELO · CIK 0001996637 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,230 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:13 UTC |
YANG MICHAEL J.Director
|
GrantStock Option (Right to Buy) · Derivative | 12,179 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001396814-24-000080 · wk-form4_1718316831.xml · derivative · entry 2 YANG MICHAEL J. · CIK 0001702283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,179 Underlying: Common Stock · 12,179 shares Expires 2034-06-12 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:13 UTC |
YANG MICHAEL J.Director
|
GrantCommon Stock | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000080 · wk-form4_1718316831.xml · nonDerivative · entry 1 YANG MICHAEL J. · CIK 0001702283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,230 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:13 UTC |
Ceesay AbrahamDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,179 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001396814-24-000079 · wk-form4_1718316820.xml · derivative · entry 2 Ceesay Abraham · CIK 0001722140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,179 Underlying: Common Stock · 12,179 shares Expires 2034-06-12 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:13 UTC |
Ceesay AbrahamDirector
|
GrantCommon Stock | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000079 · wk-form4_1718316820.xml · nonDerivative · entry 1 Ceesay Abraham · CIK 0001722140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,230 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:13 UTC |
GAUGLER DARYLChief Operating Officer
|
GrantCommon Stock | 54,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000078 · wk-form4_1718316809.xml · nonDerivative · entry 1 GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,039.584 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:13 UTC |
Young AlethiaDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,179 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001396814-24-000076 · wk-form4_1718316787.xml · derivative · entry 2 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,179 Underlying: Common Stock · 12,179 shares Expires 2034-06-12 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:13 UTC |
Young AlethiaDirector
|
GrantCommon Stock | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000076 · wk-form4_1718316787.xml · nonDerivative · entry 1 Young Alethia · CIK 0001918147 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,230 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:12 UTC |
Kronenfeld Mark A.Director
|
GrantStock Option (Right to Buy) · Derivative | 12,179 | $0.00 Strike: $28.68 | $0.00 |
DisclosureSEC source: 0001396814-24-000072 · wk-form4_1718316735.xml · derivative · entry 2 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,179 Underlying: Common Stock · 12,179 shares Expires 2034-06-12 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:12 UTC |
Kronenfeld Mark A.Director
|
GrantCommon Stock | 5,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001396814-24-000072 · wk-form4_1718316735.xml · nonDerivative · entry 1 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,902 F1 · shares: Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 22:15 UTC |
SLONIN JONATHANChief Medical Officer
|
SaleCommon Stock | 5,012 | $28.57 | $143,192.84 |
DisclosureSEC source: 0001396814-24-000084 · wk-form4_1718316890.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,569.475 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:09 UTC |
SLONIN JONATHANChief Medical Officer
|
Tax withholdingCommon Stock | 1,615 | $30.89 | $49,887.35 |
DisclosureSEC source: 0001396814-24-000051 · wk-form4_1717621737.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,581.475 F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 17:09 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
Tax withholdingCommon Stock | 2,979 | $30.89 | $92,021.31 |
DisclosureSEC source: 0001396814-24-000054 · wk-form4_1717621778.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,647 F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:09 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Tax withholdingCommon Stock | 3,011 | $30.89 | $93,009.79 |
DisclosureSEC source: 0001396814-24-000053 · wk-form4_1717621763.xml · nonDerivative · entry 1 WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,064 F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.